A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 3-4, 2011, Pages 253-259

  Dowling, Geraldine ^a   Regan, Liam ^a  

^a National Reference Laboratory for Antimicrobial Resistance Food Feed and Animal Health   (Ireland)

Author keywords

Human urine; Liquid chromatography mass spectrometry; Method validation; Spice; Synthetic cannabinoids

Indexed keywords

CANNABINOIDS; COMMISSION DECISION 2002/657/EC; DECISION LIMIT; DETECTION CAPABILITY; HUMAN URINE; LC-MS METHODS; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MEASUREMENT UNCERTAINTY; METHOD VALIDATIONS; MULTIPLE REACTION MONITORING; NON-TRADITIONAL; RAPID METHOD; REPRODUCIBILITIES; RUNTIMES; TRIPLE QUADRUPOLE TANDEM MASS SPECTROMETRY; URINE SAMPLE; VALIDATION DATA; VALIDATION PROTOCOLS;

ACETONITRILE; CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; UNCERTAINTY ANALYSIS;

BODY FLUIDS;

ACETONITRILE; CANNABINOID RECEPTOR AGONIST; CP 47 497; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; URINALYSIS;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; CYCLOHEXANOLS; FEMALE; HUMANS; LINEAR MODELS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 78751705271     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.12.008     Document Type: Article

References (14)

1. Auwarter V., Dresen S., Weinmann W., Muller M., Putz M., Ferrieros N. J. Mass. Spectrom. 2009, 44:832.
2. Understanding the" Spice" phenomenon, ISSN 17255767.
3. Uchiyama N., Kikura-Hanajiri R., Kawahara N., Haishima Y., Yukihiro Goda Chem. Pharm. Bull. 2009, 57:439.
4. Zimmermann U.S., Winkelmann P.R., Pilhatsch M., Nees J.A., Spanagel R., Schulz K. Dtsch Arzlebl Int. 2009, 106(27):464.
5. Muller H. Schizophr. Res. 2010, 118:309.
6. Vardakou I., Pistos C., Spuliopoulou Ch. Toxicol. Lett. 2010, 197:157.
7. Koe B.K., Milne G.M., Weissman A., Johnson M.R., Melvin L.S. Eur. J. Pharmacol. 1985, 109:201.
8. Compton D.R., Johnson M.R., Melvin L.S., Martin B.R. J. Pharmacol. Exp. Ther. 1992, 260:201.
9. Weissman A., Milne G.M., Melvin L.S. J. Pharmacol. Exp. Ther. 1982, 223:516.
10. T. Kraemer, K.Y. Rust, M.R. Meyer, D.K. Wissenbach, D. Bregal, M. Hopf, H.H. Maurer, J. Wilske, Poster 043 at TIAFT Meeting in Geneva, 2009.
11. Commission Decision (2002/657/EC) of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and interpretation of results, Off. J. Eur. Commun., L221, 8.
12. ISO 11843: 1997 Capability of detection-Part 1: Terms and definitions, Part 2: Methodology in the linear calibration case Part 2: Methodology in the linear calibration case.
13. Dowling G., Gallo P., Regan L. J. Chromatogr. B 2009, 877:541.
14. SANCO/2004/2726/Rev 1 Guidelines for implementation of Commission Decision 2002/657/EC.